# Consensus
Studies suggest that phosphodiesterase inhibitors, particularly PDE5 inhibitors, are effective in treating pulmonary hypertension by inducing vasodilation, reducing arterial pressure, and inhibiting smooth muscle proliferation in the pulmonary arteries.

# Associated hits
```
# CAMP ENSG00000164047, # ENPP2 ENSG00000136960, 
```